Baird lowered the firm’s price target on Agilon Health (AGL) to $1 from $5 and keeps a Neutral rating on the shares. The firm adjusted the price target after updating its power rankings in managed care and healthcare facilities.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGL:
- Agilon Health’s Earnings Call: Challenges and Optimism
- Agilon Health Faces Uncertainty Amid RAF Challenges and Leadership Changes
- Agilon Health price target lowered to $1.50 from $4 at Benchmark
- Agilon Health price target lowered to $1 from $4 at TD Cowen
- Agilon Health Reports Q2 2025 Results Amid Leadership Change